Methods A systematic review was conducted of literature published between March 2014 and March 2024
Some studies employ a loading regimen of higher initial doses followed by lower maintenance doses
The theoretical 3-8% additional weight loss from adding cagrilintide to tirzepatide doesn't justify the significantly amplified side effects, 2-3x higher cost ($1,200-2,400 monthly), lack of physician support for experimental protocols, and unknown long-term safety profile
One promising candidate is glutathionea tripeptide composed of glutamine, cysteine, and glycineknown for its potent antioxidative properties
In: Patel, V.B., Preedy, V.R
These are stronger medicines that are applied weekly or biweekly